Jounce Therapeutics, Inc. Debt to Equity Ratio 2017-2022 | JNCE
Current and historical debt to equity ratio values for Jounce Therapeutics, Inc. (JNCE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Jounce Therapeutics, Inc. debt/equity for the three months ending December 31, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-12-31 | $0.03B | $0.18B | 0.16 |
| 2022-09-30 | $0.03B | $0.13B | 0.22 |
| 2022-06-30 | $0.03B | $0.16B | 0.20 |
| 2022-03-31 | $0.03B | $0.19B | 0.14 |
| 2021-12-31 | $0.03B | $0.22B | 0.13 |
| 2021-09-30 | $0.03B | $0.25B | 0.12 |
| 2021-06-30 | $0.03B | $0.28B | 0.10 |
| 2021-03-31 | $0.03B | $0.28B | 0.09 |
| 2020-12-31 | $0.03B | $0.21B | 0.16 |
| 2020-09-30 | $0.03B | $0.11B | 0.29 |
| 2020-06-30 | $0.03B | $0.13B | 0.25 |
| 2020-03-31 | $0.03B | $0.15B | 0.20 |
| 2019-12-31 | $0.03B | $0.18B | 0.18 |
| 2019-09-30 | $0.03B | $0.19B | 0.16 |
| 2019-06-30 | $0.10B | $0.09B | 1.12 |
| 2019-03-31 | $0.12B | $0.09B | 1.26 |
| 2018-12-31 | $0.11B | $0.10B | 1.06 |
| 2018-09-30 | $0.13B | $0.10B | 1.27 |
| 2018-06-30 | $0.15B | $0.11B | 1.33 |
| 2018-03-31 | $0.17B | $0.11B | 1.50 |
| 2017-12-31 | $0.13B | $0.17B | 0.78 |
| 2017-09-30 | $0.14B | $0.18B | 0.81 |
| 2017-06-30 | $0.16B | $0.18B | 0.92 |
| 2017-03-31 | $0.18B | $0.18B | 1.03 |
| 2016-12-31 | $0.20B | $0.07B | 2.88 |
| 2016-09-30 | $0.00B | 0.00 | |
| 2016-06-30 | $0.00B | 0.00 | |
| 2016-03-31 | $0.00B | 0.00 | |
